ENTITY
Jafron Biomedical

Jafron Biomedical (300529 CH)

32
Analysis
Health Care • China
Jafron Biomedical Co., Ltd. manufactures biomaterials and medical devices. The Company researches, produces, and sells immunization adsorption, resin hemoperfusion, blood purification, resin bandage, and other related products. Jafron Biomedical markets throughout China.
more
•06 May 2025 14:15

Quiddity Leaderboard ChiNext & ChiNext 50 Jun25: Last-Minute Methodology Changes; Final Expectations

There have been some last-minute changes to the index methodology which are expected to become effective during the June 2025 index rebal event. We...

Share
•17 Apr 2025 17:50

Quiddity Leaderboard ChiNext & ChiNext 50 Jun25: Some New Expectations; Try Sector-Neutral Pairs

There could be roughly US$1.4bn in total one-way flows for ChiNext and ChiNext 50 during the June 2025 index rebalance event. Some expectations...

Share
•04 Jun 2023 05:55

Index Rebalance & ETF Flow Recap: CSI300/500, Chinext, China Semi Chips, Nifty Next50, SET50, REMX

This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...

Logo
848 Views
Share
•28 May 2023 08:12

CSI300 Index Rebalance: 9 Changes as Discretion Used

There are 9 changes for the CSI300 Index in June. Nearly all changes were forecast. Some stocks are conspicuous by their non-addition/deletion. The...

Logo
1.2k Views
Share
•25 Apr 2023 08:20

CSI300 Index Rebalance Preview: Potential Changes as Review Period Nearly Complete

There could be 13 changes to the CSI300 in June. We estimate a one-way turnover of 1.94% at the June rebalance leading to a one-way trade of CNY...

Logo
685 Views
Share
x